BCFS002018-UO-Sabb-40-[Landing Page]

Apply Now Schizophrenia Research Study This research study is testing Cobenfy, the first medication in a new class of antipsychotics approved by the FDA. Unlike existing treatments, Cobenfy works through a different mechanism of action, which may offer new benefits for people experiencing schizophrenia. The study focuses on adults who are in their first episode or […]